Article Versions Notes

Cheema PK, Iafolla MAJ, Nematollahi M, Berco F, Kaushik D, Matthews P, Raskin WR, Perdrizet KA, Dudani S, Husain J, et al. A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre. Current Oncology. 2022; 29(2):869-880. https://doi.org/10.3390/curroncol29020074

Cheema, Parneet K., Marco A. J. Iafolla, Massey Nematollahi, FeRevelyn Berco, Deepanjali Kaushik, Priscilla Matthews, William R. Raskin, Kirstin A. Perdrizet, Shaan Dudani, Juhi Husain, and et al. 2022. "A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre" Current Oncology 29, no. 2: 869-880. https://doi.org/10.3390/curroncol29020074

Cheema, P. K., Iafolla, M. A. J., Nematollahi, M., Berco, F., Kaushik, D., Matthews, P., Raskin, W. R., Perdrizet, K. A., Dudani, S., Husain, J., Balcewicz, M., Kuruvilla, P. G., Reingold, S. M., & Conter, H. J. (2022). A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre. Current Oncology, 29(2), 869-880. https://doi.org/10.3390/curroncol29020074